News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,639 Results
Type
Article (13871)
Company Profile (102)
Press Release (252666)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88283)
Career Advice (466)
Deals (15387)
Drug Delivery (67)
Drug Development (36736)
Employer Resources (49)
FDA (6312)
Job Trends (6216)
News (150641)
Policy (14070)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (444)
Accelerated approval (2)
Adcomms (6)
Allergies (33)
Alliances (23294)
ALS (39)
Alzheimer's disease (399)
Antibody-drug conjugate (ADC) (41)
Approvals (6347)
Artificial intelligence (107)
Autoimmune disease (9)
Automation (4)
Bankruptcy (150)
Best Places to Work (4382)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (41)
Bladder cancer (21)
Brain cancer (16)
Breast cancer (79)
Cancer (621)
Cardiovascular disease (72)
Career advice (409)
Career pathing (12)
CAR-T (22)
Cell therapy (88)
Cervical cancer (4)
Clinical research (31032)
Collaboration (347)
Compensation (155)
Complete response letters (17)
COVID-19 (760)
CRISPR (20)
C-suite (124)
Cystic fibrosis (37)
Data (642)
Denatured (15)
Depression (9)
Diabetes (81)
Diagnostics (1329)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (62)
Drug pricing (65)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (32226)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37696)
Executive appointments (395)
FDA (6738)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (216)
Gene editing (38)
Generative AI (9)
Gene therapy (101)
GLP-1 (350)
Government (1302)
Grass and pollen (3)
Guidances (16)
Healthcare (3584)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (35)
Indications (14)
Infectious disease (796)
Inflammatory bowel disease (55)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (47)
Interviews (59)
IPO (5900)
IRA (29)
Job creations (2055)
Job search strategy (374)
Kidney cancer (6)
Labor market (12)
Layoffs (181)
Leadership (3)
Legal (3435)
Liver cancer (21)
Lung cancer (83)
Lymphoma (55)
Machine learning (1)
Management (16)
Manufacturing (160)
MASH (32)
Medical device (1283)
Medtech (1285)
Mergers & acquisitions (9693)
Metabolic disorders (262)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (26)
Neuropsychiatric disorders (8)
Neuroscience (589)
NextGen: Class of 2025 (1599)
Non-profit (595)
Northern California (718)
Now hiring (8)
Obesity (150)
Opinion (119)
Ovarian cancer (21)
Pain (51)
Pancreatic cancer (14)
Parkinson's disease (47)
Partnered (7)
Patents (117)
Patient recruitment (29)
Peanut (10)
People (29024)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8076)
Phase II (13123)
Phase III (11786)
Pipeline (447)
Policy (72)
Postmarket research (1405)
Preclinical (3234)
Press Release (25)
Prostate cancer (46)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (168)
Real estate (2647)
Recruiting (17)
Regulatory (10147)
Reports (14)
Research institute (570)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (9)
Schizophrenia (37)
Series A (37)
Series B (13)
Service/supplier (3)
Sickle cell disease (32)
Southern California (734)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1639)
State (2)
Stomach cancer (3)
Supply chain (33)
Tariffs (26)
The Weekly (30)
United States (7315)
Vaccines (153)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (3)
Date
Today (9)
Last 7 days (214)
Last 30 days (849)
Last 365 days (11789)
2025 (3657)
2024 (12568)
2023 (14298)
2022 (19608)
2021 (20139)
2020 (19105)
2019 (14955)
2018 (11751)
2017 (13937)
2016 (13185)
2015 (15546)
2014 (12447)
2013 (10617)
2012 (11429)
2011 (11946)
2010 (10903)
Location
Africa (314)
Alabama (13)
Alaska (1)
Arizona (55)
Arkansas (3)
Asia (20191)
Australia (2621)
California (1748)
Canada (914)
China (239)
Colorado (70)
Connecticut (68)
Delaware (56)
Europe (39534)
Florida (330)
Georgia (38)
Idaho (9)
Illinois (197)
India (16)
Indiana (135)
Iowa (1)
Japan (93)
Kansas (57)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (259)
Massachusetts (1502)
Michigan (30)
Minnesota (97)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (770)
New Mexico (7)
New York (525)
North Carolina (403)
North Dakota (2)
Northern California (718)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (446)
Puerto Rico (8)
Rhode Island (10)
South America (503)
South Carolina (2)
Southern California (734)
Tennessee (34)
Texas (234)
Utah (34)
Virginia (75)
Washington D.C. (32)
Washington State (121)
Wisconsin (16)
266,639 Results for "aries pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Parallel Bio Appoints Deep Tech Innovator Ari Gesher as Head of Technology
Parallel Bio, a biotech company using the immune system to cure disease, today announced that Ari Gesher has joined as the first head of technology.
June 26, 2024
·
3 min read
Bio NC
IQVIA CEO Ari Bousbib to Speak at Morgan Stanley Annual Global Healthcare Conference on September 12, 2023
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Morgan Stanley Annual Global Healthcare Conference in New York City on Tuesday, September 12, 2023 at 11:30 a.m. ET.
September 1, 2023
·
1 min read
Business
Trinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEO
Trinity Biotech plc today announced the appointment of Mr. Aris Kekedjian as CEO with effect from October 3, 2022.
October 3, 2022
·
6 min read
Diamante Closes Euro 595,000 Seed Round Led by Arieli Capital
Diamante S.r.l., a female-led Italian biotechnology company focused on the use of plants for producing high value-added molecules, closes Euro 595K as a second Seed Round led by Arieli Capital.
January 17, 2023
·
4 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Funding
Symbiotic Capital Launches With More Than $600M to Provide Life Science Loans
Biotech entrepreneur Arie Belldegrun and former Roche CEO Franz Humer are part of the credit firm’s push to provide companies with another source of funding, Symbiotic Capital announced Tuesday.
August 6, 2024
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
X4 Pharmaceuticals Announces Reverse Stock Split
April 24, 2025
·
6 min read
Press Releases
KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
April 8, 2025
·
4 min read
Bio NC
IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2022
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Baird 2022 Global Healthcare Conference in New York City on Wednesday, September 14, 2022 at 2:35 p.m. ET.
September 2, 2022
·
1 min read
1 of 26,664
Next
